Log In
BCIQ
Print this Print this
 

TeloB-VAX

  Manage Alerts
Collapse Summary General Information
Company Adamis Pharmaceuticals Corp.
DescriptionUtilizes patients' own B cells as antigen producing and antigen presenting cells
Molecular Target Telomerase
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase I
Standard IndicationProstate cancer
Indication DetailsTreat castration-resistant prostate cancer (CRPC)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/02/2011

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today